We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

73 hedge funds and large institutions have $299M invested in Cogent Biosciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

6% more funds holding

Funds holding: 69 → 73 (+4)

5% more capital invested

Capital invested by funds: $284M → $299M (+$15.4M)

1.06% more ownership

Funds ownership: 94.74% → 95.8% (+1.1%)

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

Holders
73
Holders Change
+4
Holders Change %
+5.8%
% of All Funds
1.28%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
14
Increased
18
Reduced
19
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
Vivo Capital
California
+$10.9M
2
CC
Commodore Capital
New York
+$4.18M
3
SCM
Silverarc Capital Management
Massachusetts
+$3.68M
4
MWNA
Marshall Wace North America
New York
+$2.51M
5
PCH
Polar Capital Holdings
United Kingdom
+$1.75M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$8.11M
2
Invesco
Invesco
Georgia
-$5.5M
3
TCM
Tekla Capital Management
Massachusetts
-$4.36M
4
LGM
Logos Global Management
California
-$3.8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
51
SG Americas Securities
New York
$162K +$148K +19,307 New
VOYA Investment Management
52
VOYA Investment Management
Georgia
$126K – – –
Citadel Advisors
53
Citadel Advisors
Florida
$121K +$110K +14,340 New
MIM
54
MetLife Investment Management
New Jersey
$118K +$107K +14,022 New
Capstone Investment Advisors
55
Capstone Investment Advisors
New York
$109K +$99.1K +12,928 New
Invesco
56
Invesco
Georgia
$102K -$5.5M -717,711 -98%
TI
57
Trexquant Investment
Connecticut
$96K +$87.4K +11,407 New
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$89.2K +$81.3K +10,609 New
SO
59
STRS Ohio
Ohio
$72K – – –
Morgan Stanley
60
Morgan Stanley
New York
$68K +$3.66K +478 +6%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$32K +$9.83K +1,283 +50%
Legal & General Group
62
Legal & General Group
United Kingdom
$27K – – –
TRCT
63
Tower Research Capital (TRC)
New York
$24K -$41K -5,345 -65%
AIP
64
Ameritas Investment Partners
Nebraska
$24K – – –
GRP
65
Global Retirement Partners
California
$15K – – –
PCH
66
Polar Capital Holdings
United Kingdom
$10.3K +$1.75M +228,828 +23%
RTL
67
Red Tortoise LLC
Georgia
$5K +$2.62K +342 New
Bessemer Group
68
Bessemer Group
New Jersey
$2K – – –
TFO
69
Tarbox Family Office
California
$2K – – –
UBS Group
70
UBS Group
Switzerland
$2K +$1.98K +258 New
CAM
71
ClariVest Asset Management
California
$1K – – –
NFSG
72
Newbridge Financial Services Group
Florida
$1K – – –
Fidelity Investments
73
Fidelity Investments
Massachusetts
$1K +$667 +87 New
HA
74
HHLR Advisors
Cayman Islands
– -$8.11M -1,000,000 Closed
TCM
75
Tekla Capital Management
Massachusetts
– -$4.36M -537,742 Closed
1 2
3
4

COGT Hedge Fund Activity: Q3 2021 in Review

73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2021, worth a combined $299M — up 5.4% from $284M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COGT positions and 9 closed out — a net gain of 5 holders — while 18 added to existing stakes and 19 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $10.9M. The largest seller was HHLR Advisors, exiting entirely with an estimated $8.11M sold.

  • 73 institutional investors held Cogent Biosciences (COGT) as of Q3 2021, up from 69 in Q2 2021.
  • Funds reported $299M of Cogent Biosciences stock for Q3 2021, up 5.4% quarter-over-quarter.
  • 14 funds opened new Cogent Biosciences positions in Q3 2021 and 9 closed out, a net change of +5 holders.
  • The largest Cogent Biosciences buyer in Q3 2021 was Vivo Capital, an estimated $10.9M added.
  • The largest Cogent Biosciences seller in Q3 2021 was HHLR Advisors, an estimated $8.11M sold.

Based on aggregated 13F filings for Q3 2021.